Orchid launches rapid transplant-match system:
This article was originally published in Clinica
Orchid BioSciences' diagnostics division has introduced its LifeMatch screening technology platform, which is designed for matching compatible donors and recipients for solid organ and bone marrow transplantation. The technology, which involves human leukocyte antigen (HLA) genotyping and antibody detection, is more accurate and sensitive that conventional serological tests, says the Strasbourg, France firm. Additionally, the LifeMatch system may reduce testing turn-around time, says the company.